ArticleScientific reports2025
Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effect of subsequent passages on biofilm formation intensity, ALS genes expression, and cell surface hydrophobicity variability in clinical Candida albicans isolates.Scientific reports · 2026Article
- Antimicrobial and Antioxidant Effects of Aqueous, Methanolic, and a Deep Eutectic Solvent-Based Extracts ofScientifica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Candida onychomycosis is a common fungal nail infection where treatment efficacy can be compromised by antifungal resistance. This study investigates the role of efflux pump genes (CDR1, CDR2, and MDR1) and biofilm-associated genes (ALS1, ALS3) in Candida albicans isolates classified as resistant to itraconazole from patients with onychomycosis. Ten itraconazole-resistant and 10 sensitive isolates were collected for efflux pump and biofilm-associated gene expression analysis by Real-Time PCR methods. Itraconazole resistance was induced in sensitive isolates through pulse exposure. Biofilm formation was quantified both with and without itraconazole. Biofilm structures were visualized by scanning electron microscopy. Our findings indicate a statistically significant upregulation of CDR1 (P-value = 0.049), CDR2 (P-value = 0.023), and ALS3 (P-value = 0.010) in resistant isolates when compared to sensitive isolates. While MDR1 and ALS1 showed some variation, the differences were not statistically significant. Rhodamine 6G efflux assays demonstrated significantly higher efflux activity in resistant isolates (P-value = 0.001 at 60 min). Biofilm formation assays showed itraconazole's impact: pre-treatment reduced biofilm formation, while it had a limited effect on pre-formed biofilms. Scanning electron microscopy indicated less dense biofilms when the formation began in the presence of itraconazole. A pulse exposure to itraconazole also further upregulated CDR1, CDR2, and MDR1 in resistant isolates. Our results implicated CDR1, CDR2, and ALS3 in itraconazole resistance, suggesting their potential as therapeutic targets for future investigation. These findings emphasize the primary role of efflux pumps and biofilm-associated genes in the resistance of clinical C. albicans onychomycosis isolates, although specific mutations (e.g., ERG11, TAC1) were not examined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.